References

• Herva A, Rasanen P, Miettunen J, Timonen M, Laksy K, Veijola J, Laitinen J, Ruokonen A, Joukamaa M: Co-occurrence of metabolic syndrome with depression and anxiety in young adults: the Northern Finland 1966 Birth Control Study. Psychosom Med 2006, 68:213–216.
   PubMed Web of Science ®Google Scholar
• Kinder LS, Carnethon MR, Palaniappan LP, King AC, Fortmann SP: Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey. Psychosom Med 2004, 66:316–322.
   PubMed Web of Science ®Google Scholar
• McCaffery JM, Niaura R, Todaro JF, Swan GE, Carmelli D: Depressive symptoms and metabolic risk in adult male twins enrolled in the National Heart Lung and Blood Institute twin study. Psychosom Med 2003, 65:490–497.
   PubMed Web of Science ®Google Scholar
• Miller GE, Freedland KE, Carney RM, Stetler CA, Banks WA: Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav Immun 2003, 17:276–285.
   PubMed Web of Science ®Google Scholar
• Raikkonen K, Matthews KA, Kuller LH: The relationship between psychological risk attributes and the metabolic syndrome in healthy women: antecedent or consequence? Metabolism 2002, 51:1573–1577.
   PubMed Web of Science ®Google Scholar
• Raikkonen K, Matthews KA, Kuller LH: Depressive symptoms and stressful life events predict metabolic syndrome among middle aged women: a comparison of World Health Organization, Adult Treatment Panel III and the International Diabetes Foundation definitions. Diabetes Care 2007, 30:872–877.
   PubMed Web of Science ®Google Scholar
• Vogelzangs N, Suthers K, Ferrucci L, Simonsick EM, Ble A, Schrager M, Bandinelli S, Lauretani F, Giannelli SV, Penninx BW: Hypercortisolemic depression is associated with the metabolic syndrome in late life. Psychoneuroendocrinology 2007, 32:151–159
   PubMed Web of Science ®Google Scholar
• Skilton MR, Moulin P, Terra JL, Bonnet F: Associations between anxiety, depression and the metabolic syndrome. Biol Psychiatry 2007, 62:1251–1257.
   PubMed Web of Science ®Google Scholar
• Dunbar JA, Reddy P, Davis-Lameloise N, Philpot B, Laatikainen T, Kilkkinen A, Bunker S, Best JD, Vartainen E, Kai Lo S, Janus E: Depression: an important comorbidity with metabolic syndrome in a general population. Diabetes Care 2008, 31:2368–2373.
   PubMed Web of Science ®Google Scholar
• Miettola J, Niskanen LK, Viinamaki H, Kumpusalo E: Metabolic syndrome is associated with self-perceived depression. Scand J Prim Health Care 2008, 26:203–210.
   PubMed Web of Science ®Google Scholar
• Hildrum B, Mykletun A, Midthjell K, Ismail K, Dahl AA: No association of depression and anxiety with the metabolic syndrome: the Norwegian HUNT study. Acta Psychiatr Scand 2009, 120:14–22.
   PubMed Web of Science ®Google Scholar
• Akbaraly TN, Kivimaki M, Brunner EJ, Chandola T, Marmot MG, Singh-Manoux A, Ferrie JE: Association between metabolic syndrome and depressive symptoms in middle-aged adults. Results from the Whitehall II study. Diabetes Care 2009, 32:499–504.
   PubMed Web of Science ®Google Scholar
• Takeuchi T, Nakao M, Nomura K, Inoue M, Tsurugano S, Shinozaki Y, Yano E. Association of the metabolic syndrome with depression and anxiety in Japanese men: A 1-year cohort study. Diabetes Metab Res Rev 2009, 25:762–767.
   PubMed Web of Science ®Google Scholar
• Almeida OP, Calver J, Hankey GJ, Flicker L: Obesity and metabolic syndrome increase the risk of incident depression in older men: the health in men study. Am J Geriatr Psychiatry 2009, 17: 889–898.
   Web of Science ®Google Scholar
• Ahola AJ, Thorn LM, Saraheimo M, Forsblom C, Groop PH. Depression is associated with the metabolic syndrome among patients with type I diabetes. Ann Med 2010, 42:495–501.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Rasgon NL, Kemp DE et al: Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap. Curr Diab Rep 2009, 9:51–59.
   PubMed Web of Science ®Google Scholar
• Hayden BB, Rachel MB, Maren KO, David CS: The association of psychosocial factors and depression with hypertension among older adults. Int J Geriat Psychiatr 2003, 18:1142–1148.
   Web of Science ®Google Scholar
• Bruce SJ, Peter F, Deborah DI: Are symptoms of anxiety and depression risk factors for hypertension? Arch Fam Med 1997, 6:43–49.
   Google Scholar
• Vasiuk IA, Nesterova EA, Dovzhenko TV, Kozina AA, Sadulaeva IA, Tarasova KV: Modern antidepressants in complex management of patients with hypertension and concomitant affective disorders. Kardiologiia 2004, 44:72–79.
   Web of Science ®Google Scholar
• Sherita HG, Hochang BL, Pamela JS, Ana DR, Annette LF, Moyses S, Constantine L: Depression and type 2 diabetes mellitus: the multiethnic study of atherosclerosis. Psychosom Med 2007, 69:529–536.
   Web of Science ®Google Scholar
• Talbot F, Nouwen A: A review of the relationship between depression and diabetes in adults: is there a link? Diabetes Care 2000, 23:1556–1562.
   PubMed Web of Science ®Google Scholar
• Anderson RJ, Freedland KE, Clouse RE, Lustman PJ: The prevalence comorbid depression in adults with diabetes: a meta- analysis. Diabetes Care 2001, 24:1069–1078.
   PubMed Web of Science ®Google Scholar
• Perveen S, Otho MS, Siddiqi MN, Hatcher J, Rafique G: Association of depression with newly diagnosed type 2 diabetes among adults aged between 25 to 60 years in Karachi Pakistan. Diabetology & Metabolic Syndrome 2010, 2:17.
   Web of Science ®Google Scholar
• Sokol MC, McGuian KA, Verbrugge RR, Epstein RS: Impact of medication adherence on hospitalization risk and healthcare. Cos Med Care 2005, 43:521–530.
   PubMed Web of Science ®Google Scholar
• Lehto SM, Niskanen L, Tolmunen T, Hintikka J, Viinamaki H, Heiskanen T, Honkalampi K, Kokkonen M, Kojvumaa-Honkanen H: Low HDL-cholesterol levels are associated with long symptom duration in patients with major depressive disorder. Psychiatry Clin Neurosci 2010, 64:279–283.
   Web of Science ®Google Scholar
• Vogelzangs N, Kritchevsky SB, Beekman AT, Brenes GA, Newman AB, Satterfield S, Yaffe K, Harris TB, Penninx BW: Health ABC Study: Obesity and onset of significant depressive symptoms: Results from a prospective community based cohort study of older men and women. J Clin Psychiatry 2010, 71:391–399.
   Web of Science ®Google Scholar
• Oğuz A. Metabolic syndrome.Klinik Psikofarmakoloji Bülteni—Bulletin of Clinical Psychopharmacology 2008; 18: 57–61
   Google Scholar
• Can AS, Bersot T P: Analysis of agreement among definitions of metabolic syndrome in nondiabetic Turkish adults: a methodological study. BMC Public Health 2007,7:353 http://www.biomedcentral.com/1471-2458/7/353
   Web of Science ®Google Scholar
• Kozan O, Oguz A, Abaci A, Erol C, Ongen Z, Temizhan A, Celik S: Prevalence of the metabolic syndrome among Turkish adults. Eur J Clin Nutr 2007, 6:548–553.
   Google Scholar
• Ozsahin AK, Gokcel A, Sezgin N, Akbaba M, Guvener N, Ozisik L, Karademir BM: Prevalence of the metabolic syndrome in a Turkish adult population. Diabetes Nutr Metab 2004, 17: 230–234.
   PubMedGoogle Scholar
• Mahley RW, Palaoglu KE, Atak Z, Dawson-Pepin J, Langlois AM, Cheung V, Onat H, Fulks P, Mahley LL, Vakar F: Turkish heart study. Lipids, lipoproteins, and alipoproteins. J Lipid Res 1995, 36: 839–859.
   PubMed Web of Science ®Google Scholar
• Onat A, Ceyhan K, Başar O, Erer B, Toprak S, Sansoy V: Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels a prospective and cross-sectional evaluation. Atherosclerosis 2002, 165:285–292.
   PubMed Web of Science ®Google Scholar
• Turkish Ministry of Health., RSHC, The School of Public Health: National Burden of Disease and Cost Effectiveness Project, Burden of Disease Final Report, December 2004, Ankara, p. 240. [http://www.tusak.saglik.gov.tr/pdf/nbd/raporlar/burdenofdiseaseENG.pdf], Accessed November 9th, 2010.
   Google Scholar
• Sagduyu A, Ogel K, Ozmen E, Boratav C: Depression in Primary Health Care. Turk J Psychiatr 2000, 11:3–16.
   Google Scholar
• Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterols in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285:2486–2497.
   PubMed Web of Science ®Google Scholar
• Hisli N Beck depresyon envanterinin geçerliği üzerine bir çalışma. Psikoloji Dergisi 1988, 6:118–126. [A validation study of Beck Depression Inventory. Psychology Journal 1988, 6:118–126]
   Google Scholar
• Kobrosly RW, Van Wijngaarden E. Revisiting the association between metabolic syndrome and depressive symptoms. Ann Epidemiol 2010, 20:852–855.
   Web of Science ®Google Scholar
• Foley DL, Morley KI, Madden PA, Health AC, Whitfield JB, Martin NG. Major depression and the metabolic syndrome. Twin Res Hum Genet 2010, 13:347–358.
   PubMed Web of Science ®Google Scholar
• Roriz-Cruz M, Rosset I, Wada T. et al. Stroke independent association between metabolic syndrome and functional dependence, depression, and low quality of life in elderly community-dwelling Brazilian people. J Am Geriatr Soc 2007, 55:374–382.
   PubMed Web of Science ®Google Scholar
• Vaccarino V, McClure C, Johnson D, Sheps D, Bittner V, Rutledge T et al. Depression, the metabolic syndrome and cardiovascular risk. Psychosom Med 2008, 70:40–48.
   PubMed Web of Science ®Google Scholar
• East C, Willis BL, Barlow CE, Grannemann BD, FitzGerald SJ, DeFina LF, Trivedi MH. Depressive symptoms and metabolic syndrome in preventive healthcare: the Cooper Center longitudinal study. Metab Syndr Relat Disord 2010, 8:451–457.
   Web of Science ®Google Scholar
• Altındağ A, Demirbağ R, Saraçoğlu G. Quality of life in metabolic syndrome: The impact of comorbid psychiatric disorders. Psychiatry in Turkey 2008, 10(1):29–33 (in Turkish)
   Google Scholar
• Savaş E., Özovacı A., Kokaçya M.H., Altındağ A., Vırıt O. Frequency of metabolic syndrome in obsessive compulsive disorder patients on antidepressant monotherapy vs antidepressant plus atypical antipsychotic combination therapy: a naturalistic, descriptive pilot study. Klinik Psikofarmakoloji Bülteni—Bulletin of Clinical Psychopharmacology 2010; 20: 307–313
   Google Scholar
• Yumru M, Savaş EH. Gergerlioğlu S, Başaralı K, Kalenderoğlu A, Savaş HA, Büyükbaş S. The relationship of metabolic syndrome, serum leptin levels and treatment in bipolar disorder. Klinik Psikofarmakoloji Bülteni—Bulletin of Clinical Psychopharmacology 2008; 18: 79–83
   Google Scholar
• Usta E, Metin Ö, Birsöz S. Schizophrenia and diabetes mellitus: Diabetes mellitus or metabolic syndrome caused by new generation antipsychotics. Klinik Psikofarmakoloji Bülteni—Bulletin of Clinical Psychopharmacology 2007; 17: 207–216
   Google Scholar
• Mete L, Çetinay Ünsal P. Metabolic side effects of new generation antipsychotics. Klinik Psikofarmakoloji Bülteni—Bulletin of Clinical Psychopharmacology 2004; 14: 168–177
   Google Scholar